510(k) Report

FDA product code · Clinical chemistry

Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

QLGClass II21 CFR 862.1355510(k) required9 decisions since 20205 recalls

9 FDA decisions since 2020. 510(k) reviews decided 2021–2025 took a median of 226 days (half between 148 and 291). 5 recalls name this code, 4 of them Class I. The most-cited predicate is K193371, named by 3 later devices.

An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of QLG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QLG

2in 2023

2020: 12021: 42022: 22023: 2
2007high 4 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QLG

259in 2021

2021: 259 days median
2007high 259 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QLG

4in 2025

2023: 12025: 4, 4 Class I
2007high 4 (2025) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · QLG

20,199in 2025

2020: 1,0692021: 22,5002022: 26,5282023: 39,3212024: 35,1082025: 20,199
2007high 39,321 (2023) · low 0 (2007)2025

MAUDE reports naming product code QLG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—01,069
20214259022,500
20222—026,528
20232—139,321
20240—035,108
20250—4 (4)20,199
20260—0—
FIG. 1 — QLG by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QLG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.1355.